In terms of inflammatory therapy, thalidomide has demonstrated the ability to improve rosacea-like skin inflammation by inhibiting NF-κB activation in keratinocytes.501 Additionally, thalidomide may have therapeutic potential in tumor treatment. This evidence concerns the gene NFKB1 and neoplasm.